1. Бутрова С.А. Сибутрамин (Меридиа) в лечении ожирения: Опыт применения в России. Клин. фармакол. тер. 2001; 10 (2): 55–8.
2. Cale EE, Thun MJ., Petrelli JM et al. Body-mass index and mortality in a prospective study of the US adults. N Engl Med 1999; 341: 1097–105.
3. Davidson M et al. Control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999; 281: 235–42.
4. Sjoestroem L, Rissanen A, Andersen T et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998; 352: 167–72.
Авторы
А.М.Мкртумян
Кафедра эндокринологии и диабетологии (зав. – А.М.Мкртумян) МГМСУ, Москва